| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Syros Pharmaceuticals, Inc. (SYRS) has 0 insiders with recent SEC Form 4 filings, including 5 buys and 8 sells. SYRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Simonian Nancy A | Director | Sell | 37,070 | $0.27 | $10,016.31 | -90.3% | |
| Nov 25, 2024 | Simonian Nancy A | Director | Sell | 134,713 | $0.27 | $35,739.36 | -76.6% | |
| Nov 19, 2024 | Quirk Gerald E | Chief Legal &Compliance Offic | Sell | 46,657 | $0.22 | $10,320.53 | -100% | |
| Nov 18, 2024 | Stephens Kristin | Chief Development Officer | Sell | 36,133 | $0.22 | $7,949.26 | -100% | |
| Nov 18, 2024 | Roth David | Chief Medical Officer | Sell | 12,099 | $0.20 | $2,382.29 | -100% | |
| Nov 18, 2024 | Chee Conley | President &CEO | Sell | 134,797 | $0.20 | $26,932.44 | -100% | |
| Nov 18, 2024 | Haas Jason | Chief Financial Officer | Sell | 137,803 | $0.21 | $28,979.97 | -100% | |
| Sep 12, 2024 | Haas Jason | Chief Financial Officer | Buy | 100,000 | $1.61 | $161,239.79 | +61.1% | |
| Sep 11, 2024 | Chee Conley | President &CEO | Buy | 100,000 | $1.61 | $160,680.00 | +105.3% | |
| Jun 28, 2024 | Young Richard A | Director | Sell | 34,837 | $5.12 | $178,365.44 | -81.3% |